Materia: Medicina
Derechos de acceso: info:eu-repo/semantics/openAccess
Identificador del investigador: 0000-0001-5906-5632
Publicado por (editorial): Universitat Rovira i Virgili (URV)
Publicaciones relacionadas: Pérez-Lacasta, M. J., Martínez-Alonso, M., Garcia, M., Sala, M., Perestelo-Pérez, L., Vidal, C., Codern-Bové, N., Feijoo-Cid, M., Toledo-Chávarri, A., Cardona, À., Pons, A., Carles-Lavila, M., Rue, M., & with the InforMa Group. (2019). Effect of information about the benefits and harms of mammography on women’s decision making: The InforMa randomised controlled trial. PLOS ONE, 14(3), e0214057. https://doi.org/10.1371/journal.pone.0214057
Resumen: In Spain, women invited to breast screening are not usually informed about potential harms of screening. The objective of the InforMa study is to assess the effect of receiving information about the benefits and harms of breast screening on informed choice and other decision making outcomes, in women approaching the age of invitation to mammography screening.
Departamento: Economia
DOI: 10.5061/dryad.ft0207r
Tipo de documento: info:eu-repo/semantics/other
DOI de la publicación relacionada: 10.1371/journal.pone.0214057
Fecha alta repositorio: 2022-09-19
Autor: Pérez-Lacasta, M.
Palabras clave: Breast cancer, Medical and health sciences, Decision aids, early detection, Informed choice, Screening
Grupo de investigación: ECONOMIC CHALLENGES FOR THE NEXT GENERATION RESEARCH GROUP
Año de publicación de la dataset: 2022
Acción del progama de financiación: Instituto de Salud Carlos III, Award: PI14/00113
Título del conjunto de datos: Data from: Effect of information about the benefits and harms of mammography on women's decision making: the InforMa randomised controlled trial